Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iranian medicine formula for women with subclinical hypothyroidism
IRCT20220920056005N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of levothyroxine sodium in hypothyroidism (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: TSH, Free T4 and 2 more. Started Jun 2023; status: completed.
02
Drugs
levothyroxine sodium
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on IRCT20220920056005N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220920056005N1.